Srirang Ramamoorthy

Srirang Ramamoorthy

Active Director Director DIN 03636570
DIN 03636570 First appointment Dec 2011 Primary industry Research & Development
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Dec 2011
Shareholding value •••• Premium profile

About Srirang Ramamoorthy

Data last updated:

Srirang Ramamoorthy is a Director at Ikanekt Research And Development Private Limited (since 2018), Director at Ikanekt Biomedical Technologies Private Limited (since 2023) and Director at Cness Software India Private Limited (since 2024). The companies operate in Research & Development, Software and E-Commerce. The 2 current companies with reported revenue have a combined latest revenue of ₹24.1 Lakh; the largest is Ikanekt Research And Development Private Limited at ₹18 Lakh (FY 2022). Earlier, Srirang Ramamoorthy was a Director at Biokart India Private Limited (2011–2015) and Director at Kanekt Biomedical Technologies Private Limited (from 2015).

DIN 03636570
Primary Designation Director
Industry Research & Development
First Appointment 22 Dec 2011
Oldest Company Age 11 yrs
Largest company Ikanekt Research And Development Private Limited · ₹18 Lakh (FY 2022)
Combined revenue ₹24.1 Lakh across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Oct 20182018₹18 Lakh (FY 2022)Active
Director22 Feb 20232023₹6.1 Lakh (FY 2025)Active
Cness Software India Private Limited U62013TZ2024PTC031883
Director27 Jun 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biokart India Private Limited U74900KA2011PTC061787
Director22 Dec 20112011₹2.56 Cr (FY 2024)Active
Director29 Jul 20152015Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ikanekt Biomedical Technologies Private Limited
Ikanekt Research And Development Private Limited
Kanekt Biomedical Technologies Private Limited
Cness Software India Private Limited
Premium access

Shareholding and investment profile for Srirang Ramamoorthy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srirang Ramamoorthy

Srirang Ramamoorthy currently holds 3 directorships: Ikanekt Research And Development Private Limited (Director, since 23 Oct 2018, revenue ₹18 Lakh (FY 2022)); Ikanekt Biomedical Technologies Private Limited (Director, since 22 Feb 2023, revenue ₹6.1 Lakh (FY 2025)); Cness Software India Private Limited (Director, since 27 Jun 2024).

Srirang Ramamoorthy was first appointed on 22 Dec 2011 as Director at Biokart India Private Limited. The most recent appointment on record is 27 Jun 2024 at Cness Software India Private Limited.

The 2 current companies of Srirang Ramamoorthy that report revenue have a combined latest revenue of ₹24.1 Lakh: Ikanekt Research And Development Private Limited ₹18 Lakh (FY 2022); Ikanekt Biomedical Technologies Private Limited ₹6.1 Lakh (FY 2025).

Srirang Ramamoorthy held 2 earlier board appointments: Biokart India Private Limited (Director, 22 Dec 2011 to 19 Mar 2015); Kanekt Biomedical Technologies Private Limited (Director, from 29 Jul 2015).

The current boards of Srirang Ramamoorthy's companies include Suchithra Sreedhar (Ikanekt Research And Development Private Limited), Diddigi Vimal Bhardwaj (Ikanekt Biomedical Technologies Private Limited), Vajramuni Balaramaiah (Ikanekt Biomedical Technologies Private Limited), Tharani Tharan Thandapani (Cness Software India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available